BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25416317)

  • 21. Esthesioneuroblastoma of the pituitary gland: a clinicopathological entity? Case report and review of the literature.
    Mariani L; Schaller B; Weis J; Ozdoba C; Seiler RW
    J Neurosurg; 2004 Dec; 101(6):1049-52. PubMed ID: 15597768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcription Factor Expression in Sinonasal Neuroendocrine Neoplasms and Olfactory Neuroblastoma (ONB): Hyams' Grades 1-3 ONBs Expand the Spectrum of SATB2 and GATA3-Positive Neoplasms.
    Uccella S; Facco C; Chiaravalli AM; Pettenon F; La Rosa S; Turri-Zanoni M; Castelnuovo P; Cerati M; Sessa F
    Endocr Pathol; 2022 Jun; 33(2):264-273. PubMed ID: 35522392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Esthesioneuroblastoma of nasal cavity and ethmoid sinus].
    Popko E; Popko M; Famulski W
    Otolaryngol Pol; 2002; 56(2):235-7. PubMed ID: 12094652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The added value of 18F-FDG PET/CT for evaluation of patients with esthesioneuroblastoma.
    Broski SM; Hunt CH; Johnson GB; Subramaniam RM; Peller PJ
    J Nucl Med; 2012 Aug; 53(8):1200-6. PubMed ID: 22728262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoscopic-assisted excision of esthesioneuroblastoma.
    Prasad KC; Kumar A; Prasad SC; Jain D
    J Craniofac Surg; 2007 Sep; 18(5):1034-8. PubMed ID: 17912077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence-based practice: endoscopic skull base resection for malignancy.
    Rawal RB; Gore MR; Harvey RJ; Zanation AM
    Otolaryngol Clin North Am; 2012 Oct; 45(5):1127-42. PubMed ID: 22980689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical analysis of 53 cases of esthesioneuroblastoma].
    Chen YF; Yang AK; Zhang Q; Ouyang D; Chen WK; Chen FJ
    Ai Zheng; 2009 Mar; 28(3):308-11. PubMed ID: 19619448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term oncologic outcomes in esthesioneuroblastoma: An institutional experience of 143 patients.
    McMillan RA; Van Gompel JJ; Link MJ; Moore EJ; Price DL; Stokken JK; Van Abel KM; O'Byrne J; Giannini C; Chintakuntlawar A; Pinheiro Neto CD; Peris Celda M; Foote R; Choby G
    Int Forum Allergy Rhinol; 2022 Dec; 12(12):1457-1467. PubMed ID: 35385606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Olfactory neuroblastoma with unusual structures: a clinical pathologic study].
    Yao Q; Yue CL; Lü ZC; Han YD; Liu HG
    Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):163-8. PubMed ID: 19575850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Olfactory esthesioneuromas].
    Martel J; Darrouzet V; Duclos JY; Bébéar JP; Stoll D
    Rev Laryngol Otol Rhinol (Bord); 2000; 121(4):227-36. PubMed ID: 11233705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Late neck metastasis in esthesioneuroblastoma: a case report].
    Damar M; Başerer N; Ozkara S; Yılmazer R
    Kulak Burun Bogaz Ihtis Derg; 2012; 22(4):228-31. PubMed ID: 22770259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Olfactory neuroblastoma (esthesioneuroblastoma) and esthesioneuroepithelioma: histologic and immunohistochemical study.
    Taraszewska A; Czorniuk-Sliwa A; Dambska M
    Folia Neuropathol; 1998; 36(2):81-6. PubMed ID: 9757618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictability of Olfactory Neuroblastoma Staging Systems.
    Sun R; Seibert TM; Wei LJ
    JAMA Otolaryngol Head Neck Surg; 2024 Jan; 150(1):84-85. PubMed ID: 37971764
    [No Abstract]   [Full Text] [Related]  

  • 34. Human achaete-scute homologue (hASH1) mRNA level as a diagnostic marker to distinguish esthesioneuroblastoma from poorly differentiated tumors arising in the sinonasal tract.
    Mhawech P; Berczy M; Assaly M; Herrmann F; Bouzourene H; Allal AS; Dulguerov P; Schwaller J
    Am J Clin Pathol; 2004 Jul; 122(1):100-5. PubMed ID: 15272537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictability of Olfactory Neuroblastoma Staging Systems-Reply.
    Choby G; O'Byrne J
    JAMA Otolaryngol Head Neck Surg; 2024 Jan; 150(1):85. PubMed ID: 37971766
    [No Abstract]   [Full Text] [Related]  

  • 36. Patterns of failure and outcome in esthesioneuroblastoma.
    Dias FL; Sa GM; Lima RA; Kligerman J; Leoncio MP; Freitas EQ; Soares JR; Arcuri RA
    Arch Otolaryngol Head Neck Surg; 2003 Nov; 129(11):1186-92. PubMed ID: 14623748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Olfactory neuroblastoma (esthesioneuroblastoma)].
    Ohnishi T
    Ryoikibetsu Shokogun Shirizu; 2000; (28 Pt 3):92-5. PubMed ID: 11043192
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinicopathologic Features and Prognosis of Olfactory Neuroblastoma with Isocitrate Dehydrogenase 2 Mutations.
    Wu L; An J; Liu H
    World Neurosurg; 2022 Mar; 159():e23-e31. PubMed ID: 34856401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Esthesioneuroblastoma: the Northwestern University experience.
    Argiris A; Dutra J; Tseke P; Haines K
    Laryngoscope; 2003 Jan; 113(1):155-60. PubMed ID: 12514401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Esthesioneuroblastoma.
    Brown SR
    Otolaryngol Head Neck Surg; 2007 Nov; 137(5):835-6. PubMed ID: 17967657
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.